Govt Job for M.Pharm, M.Sc in Government of India Research Project

Manipal Academy of Higher Education is a globally engaged institution with active partnership with more than 220 leading universities around the globe.

Our relations with institutions, government agencies and organisations in study, research and service provide faculty and students access to world-class institutions, experiences and resources.

Applications are invited from the eligible candidates for the position of Junior Research Fellow (purely on temporary basis) for the research project related to “Novel Nanoparticle Approaches for Prognosis of Breast and Other Cancers Through Sentinel Lymph Node” sponsored by Department of Atomic Energy, Board of Research in Nuclear Sciences (BRNS), Govt. of India at Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal

Post : Junior Research Fellow
Duration of the Project : 3 Years

Eligibility and Qualification of the candidate :
Essential :
• MPharm (Pharmaceutics/ Industrial Pharmacy/ related specialization) OR
• MTech (Chemical/ Biomedical/ Nanotechnology/ Related specialization) OR
• MSc (Nanotechnology/ Nuclear Medicine/ Related specialization).
The candidates should have secured the PG Degree. The candidates who have given exams/ waiting for results need not apply.

Desirable :
• Research experience after Post Graduate degree
• Research experience in drug delivery/ nanotechnology/ relevant domain
• Publications/ Patents
• Good communication and writing skills

Candidates possessing requisite qualification may send their detailed CV on or before 10-August-2021 to the below address. Short-listed candidates will be called for the interview. Interview date, time and venue will be informed to shortlisted candidates via email. No TA/DA will be provided for attending the interview.

The Principal
Manipal College of Pharmaceutical Sciences
Manipal University
Manipal – 576104, Karnataka
Email: est.mcops@manipal.edu
ss.mutalik@manipal.edu

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework